1
|
Moyret-Lalle C, Prodhomme MK, Burlet D, Kashiwagi A, Petrilli V, Puisieux A, Seimiya H, Tissier A. Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment. Cancer Sci 2022; 113:2214-2223. [PMID: 35534984 PMCID: PMC9277259 DOI: 10.1111/cas.15389] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 04/20/2022] [Accepted: 04/25/2022] [Indexed: 11/30/2022] Open
Abstract
Numerous epithelial–mesenchymal transition (EMT) characteristics have now been demonstrated to participate in tumor development. Indeed, EMT is involved in invasion, acquisition of stem cell properties, and therapy‐associated resistance of cancer cells. Together, these mechanisms offer advantages in adapting to changes in the tumor microenvironment. However, recent findings have shown that EMT‐associated transcription factors (EMT‐TFs) may also be involved in DNA repair. A better understanding of the coordination between the DNA repair pathways and the role played by some EMT‐TFs in the DNA damage response (DDR) should pave the way for new treatments targeting tumor‐specific molecular vulnerabilities, which result in selective destruction of cancer cells. Here we review recent advances, providing novel insights into the role of EMT in the DDR and repair pathways, with a particular focus on the influence of EMT on cellular sensitivity to damage, as well as the implications of these relationships for improving the efficacy of cancer treatments.
Collapse
Affiliation(s)
- Caroline Moyret-Lalle
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Centre of Lyon, Lyon, France.,LabEx DEVweCAN, Université de Lyon, Lyon, France
| | - Mélanie K Prodhomme
- Department of Epigenetics & Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Delphine Burlet
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Centre of Lyon, Lyon, France
| | - Ayaka Kashiwagi
- Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.,Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
| | - Virginie Petrilli
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Centre of Lyon, Lyon, France
| | - Alain Puisieux
- Institut Curie, Versailles Saint-Quentin-en-Yvelines University, PSL Research University, Paris, France
| | - Hiroyuki Seimiya
- Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.,Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
| | - Agnès Tissier
- Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Centre of Lyon, Lyon, France
| |
Collapse
|
2
|
Barthel H, Darne C, Gaté L, Visvikis A, Seidel C. Continuous Long-Term Exposure to Low Concentrations of MWCNTs Induces an Epithelial-Mesenchymal Transition in BEAS-2B Cells. NANOMATERIALS (BASEL, SWITZERLAND) 2021; 11:1742. [PMID: 34361127 PMCID: PMC8308165 DOI: 10.3390/nano11071742] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Revised: 06/23/2021] [Accepted: 06/28/2021] [Indexed: 11/16/2022]
Abstract
In the field of nanotechnology, the use of multi-walled carbon nanotubes (MWCNTs) is growing. Pulmonary exposure during their production, use, and handling is raising concerns about their potential adverse health effects. The purpose of this study is to assess how the physical characteristics of MWCNTs, such as diameter and/or length, can play a role in cellular toxicity. Our experimental design is based on the treatment of human bronchial epithelial cells (BEAS-2B) for six weeks with low concentrations (0.125-1 µg/cm2) of MWCNTs having opposite characteristics: NM-403 and Mitsui-7. Following treatment with both MWCNTs, we observed an increase in mitotic abnormalities and micronucleus-positive cells. The cytotoxic effect was delayed in cells treated with NM-403 compared to Mitsui-7. After 4-6 weeks of treatment, a clear cellular morphological change from epithelial to fibroblast-like phenotype was noted, together with a change in the cell population composition. BEAS-2B cells underwent a conversion from the epithelial to mesenchymal state as we observed a decrease in the epithelial marker E-cadherin and an increased expression of mesenchymal markers N-cadherin, Vimentin, and Fibronectin. After four weeks of recovery, we showed that the induced epithelial-mesenchymal transition is reversible, and that the degree of reversibility depends on the MWCNT.
Collapse
Affiliation(s)
- Hélène Barthel
- Institut National de Recherche et de Sécurité, CEDEX, F-54519 Vandœuvre-lès-Nancy, France; (H.B.); (C.D.); (L.G.)
- Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Biopôle, Campus Biologie Santé, UMR 7365 CNRS-Université de Lorraine, CEDEX, F-54000 Vandœuvre-lès-Nancy, France;
| | - Christian Darne
- Institut National de Recherche et de Sécurité, CEDEX, F-54519 Vandœuvre-lès-Nancy, France; (H.B.); (C.D.); (L.G.)
| | - Laurent Gaté
- Institut National de Recherche et de Sécurité, CEDEX, F-54519 Vandœuvre-lès-Nancy, France; (H.B.); (C.D.); (L.G.)
| | - Athanase Visvikis
- Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Biopôle, Campus Biologie Santé, UMR 7365 CNRS-Université de Lorraine, CEDEX, F-54000 Vandœuvre-lès-Nancy, France;
| | - Carole Seidel
- Institut National de Recherche et de Sécurité, CEDEX, F-54519 Vandœuvre-lès-Nancy, France; (H.B.); (C.D.); (L.G.)
| |
Collapse
|
3
|
Zajac O, Jaulin F. [Upside-down topology in metastatic colorectal carcinomas]. Med Sci (Paris) 2018; 34:768-771. [PMID: 30451665 DOI: 10.1051/medsci/2018195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - Fanny Jaulin
- Institut Gustave Roussy, 114, rue Édouard Vailland, B2M, 94800 Villejuif, France
| |
Collapse
|
4
|
Abstract
What is a stem cell? Is stemness an intrinsic or extrinsic property? What role does the microenvironment play in the stemness identity? We distinguish four identities for normal and cancerous stem cells and explore their consequences for therapeutic strategy choice in the oncology setting. Acquisition of genetic and epigenetic alterations during cell transformation and disease progression questions the stability of the stemness property's identity in cancers.
Collapse
Affiliation(s)
- Lucie Laplane
- CNRS U8590 - Institut d'histoire et de philosophie des sciences et des techniques (IHPST), université Paris I Panthéon-Sorbonne, 13, rue du Four, 75006 Paris, France - Inserm U1170, Gustave Roussy, 114, rue Edouard Vaillant, 94800 Villejuif, France
| | - Éric Solary
- Inserm U1170, Gustave Roussy, 114, rue Edouard Vaillant, 94800 Villejuif, France - Faculté de médecine Paris-Sud, 94270 Le Kremlin-Bicêtre, France
| |
Collapse
|
5
|
Lopresti A, Acquaviva C, Birnbaum D, Mamessier É. [Circulating tumor cells: a real time dive into malignant plasticity]. Med Sci (Paris) 2017; 33:491-493. [PMID: 28612723 DOI: 10.1051/medsci/20173305011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Alexia Lopresti
- Oncologie moléculaire, équipe CTCs, métastases; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Université Aix-Marseille UM105; 27, boulevard Lei Roure, BP30059, 13273 Marseille, France
| | - Claire Acquaviva
- Oncologie moléculaire, équipe CTCs, métastases; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Université Aix-Marseille UM105; 27, boulevard Lei Roure, BP30059, 13273 Marseille, France
| | - Daniel Birnbaum
- Oncologie moléculaire, équipe CTCs, métastases; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Université Aix-Marseille UM105; 27, boulevard Lei Roure, BP30059, 13273 Marseille, France
| | - Émilie Mamessier
- Oncologie moléculaire, équipe CTCs, métastases; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Université Aix-Marseille UM105; 27, boulevard Lei Roure, BP30059, 13273 Marseille, France
| |
Collapse
|
6
|
Blomme A, Cusumano P, Peulen O, Bellahcène A, Castronovo V, Turtoi A. [Asporin: the protective wall against triple-negative breast cancer]. Med Sci (Paris) 2016; 32:1019-1022. [PMID: 28008845 DOI: 10.1051/medsci/20163211020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Arnaud Blomme
- Metastasis Research Laboratory, GIGA-Cancer, University of Liege, avenue de l'Hôpital 3, 4000 Liege, Belgique
| | - Pino Cusumano
- Metastasis Research Laboratory, GIGA-Cancer, University of Liege, avenue de l'Hôpital 3, 4000 Liege, Belgique - Department of senology, university hospital (CHU), University of Liège, Liège, Belgique
| | - Olivier Peulen
- Metastasis Research Laboratory, GIGA-Cancer, University of Liege, avenue de l'Hôpital 3, 4000 Liege, Belgique
| | - Akeila Bellahcène
- Metastasis Research Laboratory, GIGA-Cancer, University of Liege, avenue de l'Hôpital 3, 4000 Liege, Belgique
| | - Vincent Castronovo
- Metastasis Research Laboratory, GIGA-Cancer, University of Liege, avenue de l'Hôpital 3, 4000 Liege, Belgique
| | - Andrei Turtoi
- Metastasis Research Laboratory, GIGA-Cancer, University of Liege, avenue de l'Hôpital 3, 4000 Liege, Belgique - Institut de Recherche en Cancérologie de Montpellier ; Inserm U1194, Montpellier F-34298, France
| |
Collapse
|